GSK3A and melanoma: Indeed, we have also observed that inhibiting GSK3α/β in melanoma cell lines carrying a classical exon-3 mutation (β-catenin p.S37F [29]) in the GSK3α/β consensus site did not have any effect on SOX10 protein levels.